Miroo Kim

Miroo Kim is a seasoned professional in the field of biotechnology, currently serving as a Senior Scientist at Sarepta Therapeutics since May 2023, where leadership in AAV formulation development for early-stage gene therapy projects is a primary focus. Previously, Miroo Kim held several positions at GC Biopharma from December 2014 to May 2023, managing drug product development projects and overseeing early formulation screenings for biologics targeting rare diseases. Notable achievements include significant advancements in the formulation and manufacturing processes of plasma-derived proteins and successful collaborations with biotech companies in the US. Earlier experience includes a role as a Research Associate at Raphas, where Miroo Kim played a crucial role in establishing a microneedle production line and commercializing innovative cosmeceutical products. Educational credentials include a PhD and a Bachelor's degree in Biotechnology from Yonsei University.